RemSleep Holdings, Inc. (OTCMKTS:RMSL) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

RemSleep Holdings, Inc. (OTCMKTS:RMSL) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR

On June 15, 2017, we filed a Certificate of Amendment to our Articles of Incorporation (the "Certificate of Amendment"), with the Secretary of State of the State of Nevada to affect a 1-for-20 reverse stock split of our common stock (the "Reverse Stock Split"), whereby every 20 shares of our old common stock will be converted into 1 share of new common stock. On May 9, 2017, our Board of Directors approved the Certificate of Amendment, and our stockholders, acting by written consent of the holders of 71% of our outstanding common stock, approved the Reverse Stock Split.

On June 29, 2017, FINRA announced the Reverse Stock Split. The Reverse Stock Split took effect at the open of business on June 30, 2017. Our new symbol will be RMSLD on the otcmarket.com “Pink Sheets” for a period of 20 business days. The “D” will be removed in 20 business days at which time our symbol will revert to RMSL.

A copy of the filed Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(a) Exhibits. The following exhibit is filed with this Current Report on Form 8-K:

Exhibit No. Description

3.1 Certificate of Amendment of Remsleep Holdings, Inc. (Reverse Stock Split).



RemSleep Holdings Inc. Exhibit

To view the full exhibit click here
About RemSleep Holdings, Inc. (OTCMKTS:RMSL)

REMSleep Holdings, Inc. is a development-stage company. The Company is engaged in developing and distributing products to help people affected by sleep apnea. It offers DeltaWave continuous positive airway pressure (CPAP) interface, a design that addresses the issues that continue to affect a patient’s ability to comply with treatment. The DeltaWave interface does not disrupt normal breathing mechanics, is not claustrophobic, causes zero work of breathing (WOB), minimizes or eliminates drying of the sinuses, and uses less driving pressure. The Company was a mineral acquisition, exploration and development company focused primarily on gold properties. As of December 31, 2014, the Company had not generated any revenue.

An ad to help with our costs